AF

Acutus Medical IncNASDAQ AFIB Stock Report

Last reporting period 31 Dec, 2023

Updated 23 Dec, 2024

Last price

Market cap $B

0.003

Micro

Exchange

XNAS - Nasdaq

AFIB Stock Analysis

AF

Uncovered

Acutus Medical Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-48/100

Low score

Market cap $B

0.003

Dividend yield

Shares outstanding

28.452 B

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. The company is headquartered in Carlsbad, California. The company went IPO on 2020-08-06. design, manufacture and market a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The firm's lead product is its AcQMap imaging and mapping system, which offers a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias. The company designed AcQMap System to improve procedure efficiency and outcomes by rapidly identifying ablation targets and confirming both ablation success and procedure completion. Its AcQMap System consists of single-use AcQMap catheter, as well as its console, workstation and software algorithms. Its subsidiary is Acutus Medical NV.

View Section: Eyestock Rating